
GC17015
DRB
Also known as 2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II and CDKs· DRB trigger p53-dependent apoptosis of human colon adenocarcinoma cells without inducing genotoxic stress to healthy cells
ChemicalCAS53-85-0MW319.1FormulaC12H12Cl2N2O4
- CAS number
- 53-85-0
- Molecular weight
- 319.1
- Formula
- C12H12Cl2N2O4
- Solubility
- ≥ 12·6mg/mL in DMSO
- InChIKey
- XHSQDZXAVJRBMX-UHFFFAOYSA-N
- Catalogue number
- GC17015
- Brand
- GLPBIO
Computed properties PubChem CID 3165 · XLogP 1.1 · TPSA 87.7 Ų · H-bond donors 3
- XLogP
- 1.1
- TPSA
- 87.7 Ų
- H-bond donors
- 3
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 20
SMILES C1=C2C(=CC(=C1Cl)Cl)N(C=N2)C3C(C(C(O3)CO)O)O
Computed descriptors from PubChem (CID 3165), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il